Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Botticelli

Showing results (1-10 of 191) with videos related to

Pageof 20
Sort By:
Oral Oncology|December 5, 2021
Cetuximab: Its role in patients unfit for cisplatinFrancesca De Felice, Andrea Botticelli
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 6, 2022
Ideal regimen for induction chemotherapy in nasopharyngeal cancer: Still a hot issue?Francesca De Felice, Alessio Cirillo, Andrea Botticelli
Translational Lung Cancer Research|May 22, 2018
Nivolumab in pretreated non-small cell lung cancer: continuing the immunolutionMassimiliano Salati, Cinzia Baldessari, Bruna Cerbelli, et al.
Pharmacogenomics|June 9, 2017
Pharmacogenetics and aromatase inhibitor induced side effects in breast cancer patientsValentina Sini, Andrea Botticelli, Gianluigi Lunardi, et al.
International Journal of Molecular Sciences|April 20, 2019
CAR-T with License to Kill Solid Tumors in Search of a Winning StrategyBenedetto Sacchetti, Andrea Botticelli, Luca Pierelli, et al.
Journal of Translational Medicine|November 26, 2020
Agnostic evaluation of ipilimumab and nivolumab association: a metanalysisPaolo Marchetti, Andrea Botticelli, Antonio Paolo Ascierto, et al.
Expert Review of Anticancer Therapy|April 27, 2024
The multidisciplinary management of locally advanced rectal cancerFrancesca De Felice, Michelangelo Miccini, Andrea Botticelli, et al.
Immunotherapy|June 4, 2020
Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitorsPatrizia Vici, Laura Pizzuti, Eriseld Krasniqi, et al.
Cancer Treatment Reviews|May 28, 2021
Precision medicine in breast cancer: From clinical trials to clinical practiceEdoardo Crimini, Matteo Repetto, Philippe Aftimos, et al.
European Journal of Pharmacology|August 26, 2019
Drug resistance of BRAF-mutant melanoma: Review of up-to-date mechanisms of action and promising targeted agentsAlessandro Rossi, Michela Roberto, Martina Panebianco, et al.
Pageof 20

Showing results (1-10 of 191) with videos related to

Sort By:
Pageof 20
Oral Oncology|December 5, 2021
Cetuximab: Its role in patients unfit for cisplatinFrancesca De Felice, Andrea Botticelli
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 6, 2022
Ideal regimen for induction chemotherapy in nasopharyngeal cancer: Still a hot issue?Francesca De Felice, Alessio Cirillo, Andrea Botticelli
Translational Lung Cancer Research|May 22, 2018
Nivolumab in pretreated non-small cell lung cancer: continuing the immunolutionMassimiliano Salati, Cinzia Baldessari, Bruna Cerbelli, et al.
Pharmacogenomics|June 9, 2017
Pharmacogenetics and aromatase inhibitor induced side effects in breast cancer patientsValentina Sini, Andrea Botticelli, Gianluigi Lunardi, et al.
International Journal of Molecular Sciences|April 20, 2019
CAR-T with License to Kill Solid Tumors in Search of a Winning StrategyBenedetto Sacchetti, Andrea Botticelli, Luca Pierelli, et al.
Journal of Translational Medicine|November 26, 2020
Agnostic evaluation of ipilimumab and nivolumab association: a metanalysisPaolo Marchetti, Andrea Botticelli, Antonio Paolo Ascierto, et al.
Expert Review of Anticancer Therapy|April 27, 2024
The multidisciplinary management of locally advanced rectal cancerFrancesca De Felice, Michelangelo Miccini, Andrea Botticelli, et al.
Immunotherapy|June 4, 2020
Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitorsPatrizia Vici, Laura Pizzuti, Eriseld Krasniqi, et al.
Cancer Treatment Reviews|May 28, 2021
Precision medicine in breast cancer: From clinical trials to clinical practiceEdoardo Crimini, Matteo Repetto, Philippe Aftimos, et al.
European Journal of Pharmacology|August 26, 2019
Drug resistance of BRAF-mutant melanoma: Review of up-to-date mechanisms of action and promising targeted agentsAlessandro Rossi, Michela Roberto, Martina Panebianco, et al.
Pageof 20